Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials.

MLA

Lu, Fenping, et al. “Efficacy and Safety of Second-Line Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials.” BMC Cancer, vol. 24, no. 1, Aug. 2024, p. 1023. EBSCOhost, https://doi.org/10.1186/s12885-024-12780-y.

APA

Lu, F., Zhao, K., Ye, M., Xing, G., Liu, B., Li, X., Ran, Y., Wu, F., Chen, W., & Hu, S. (2024). Efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of randomized controlled trials. BMC Cancer, 24(1), 1023. https://doi.org/10.1186/s12885-024-12780-y

Chicago

Lu, Fenping, Kai Zhao, Miaoqing Ye, Guangyan Xing, Bowen Liu, Xiaobin Li, Yun Ran, Fenfang Wu, Wei Chen, and Shiping Hu. 2024. “Efficacy and Safety of Second-Line Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Randomized Controlled Trials.” BMC Cancer 24 (1): 1023. doi:10.1186/s12885-024-12780-y.